Clinico-radiological correlation and prognostic value of baseline chest computed tomography in eosinophilic granulomatosis with polyangiitis.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
03 10 2023
Historique:
received: 16 11 2022
accepted: 20 01 2023
medline: 5 10 2023
pubmed: 16 2 2023
entrez: 15 2 2023
Statut: ppublish

Résumé

While chest high-resolution CT (HRCT) is correlated to severity and prognosis in asthma, it has not been studied in eosinophilic granulomatosis with polyangiitis (EGPA). Our objective is to study the prognostic value of baseline HRCT in EGPA patients. Retrospective, multicentre observational study in three French hospitals, including EGPA patients with available chest HRCT before any systemic treatment. Two experienced radiologists blinded to clinical data evaluated HRCT images using semi-quantitative scoring. HRCT characteristics were correlated with clinical features and outcome. Among 46 patients, 38 (82.6%) had abnormal parenchymal findings on HRCT, including bronchial wall thickening (69.6%), mosaic perfusion (63.0%), ground-glass opacities (32.6%), bronchiectasis (30.4%), mucous plugging (21.7%) and consolidations (17.4%). Patients were clustered into three groups depending on HRCT features: ground-glass pattern, i.e. with ground-glass opacities with or without bronchial abnormalities (group 1, 28.3%), bronchial pattern (group 2, 41.3%) and extra-pulmonary pattern with no significant abnormality (group 3, 30.4%). Group 2 showed less frequent cardiac involvement (31.6 vs 46.2 and 42.9% in groups 1 and 3), more frequent positive ANCA (52.6 vs 0.0 and 14.3%) and higher eosinophil count (median 7510 vs 4000 and 4250/mm3). Group 1 showed worse prognosis with more frequent steroid-dependency (58.3 vs 11.1 and 28.6%) and requirement for mepolizumab (25.0 vs 11.1 and 7.1%). Conversely, group 2 showed a better outcome with higher rates of remission (88.9 vs 41.6 and 71.4%). Chest HRCT at diagnosis of EGPA may have prognostic value and help clinicians better manage these patients.

Identifiants

pubmed: 36790066
pii: 7039677
doi: 10.1093/rheumatology/kead077
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3350-3357

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Florence Delestre (F)

Service de Médecine Interne, Centre de Référence Maladies Systémiques Auto-Immunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre Université de Paris (CUP), Paris, France.
Université de Paris, Paris, France.

Anne-Laure Brun (AL)

Service de Radiologie, Hôpital Foch, Suresnes, France.

Benjamin Thoreau (B)

Service de Médecine Interne, Centre de Référence Maladies Systémiques Auto-Immunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre Université de Paris (CUP), Paris, France.
Université de Paris, Paris, France.

Camille Taillé (C)

Université de Paris, Paris, France.
Service de Pneumologie, Hôpital Bichat, AP-HP-Nord Université de Paris (NUP), Paris, France.

Nicolas Limal (N)

Service de Médecine Interne, Hôpital Henri Mondor, Université Paris Est Créteil, AP-HP, Créteil, France.

Xavier Puéchal (X)

Service de Médecine Interne, Centre de Référence Maladies Systémiques Auto-Immunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre Université de Paris (CUP), Paris, France.
Université de Paris, Paris, France.

Luc Mouthon (L)

Service de Médecine Interne, Centre de Référence Maladies Systémiques Auto-Immunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre Université de Paris (CUP), Paris, France.
Université de Paris, Paris, France.

Loïc Guillevin (L)

Service de Médecine Interne, Centre de Référence Maladies Systémiques Auto-Immunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre Université de Paris (CUP), Paris, France.
Université de Paris, Paris, France.

Marie-Pierre Revel (MP)

Université de Paris, Paris, France.
Service de Radiologie, Hôpital Cochin, AP-HP.CUP, Paris, France.

Benjamin Terrier (B)

Service de Médecine Interne, Centre de Référence Maladies Systémiques Auto-Immunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP)-Centre Université de Paris (CUP), Paris, France.
Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH